Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.054 | 0.7 |